The whole exome sequencing market was valued at US$ 755.68 million in 2018 and it is projected to reach US$ 3,812.0 million in 2027; it is expected to grow at a CAGR of 19.8% from 2019 to 2027.
Whole exome is a genomic technique for sequencing all of the protein-coding region of genes in a genome. Whole exome sequencing (WES) is available to patients who are searching for a unifying diagnosis for multiple medical conditions. Exome sequencing using exome enrichment can efficiently detect coding variants across a wide range of applications, including population genetics, genetic disease and cancer studies. The growth of the global whole exome sequencing market is attributed to the reduction in time and cost for sequencing, rising need of molecular diagnosis and increasing application in drug discovery. However, ethical, social and legal concerns for whole exome sequencing and dearth of highly skilled professionals are the major factor hindering the market growth.
The global whole exome sequencing market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.
Lucrative Regions for Global Whole Exome Sequencing Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Reduction in Time and Cost for Sequencing to Drive Global Whole Exome Sequencing Market Growth
The exon is part of a genome which is responsible for making 1 or 2 percent of the entire genome of a person. All of the exon in a genome are together known as the exome. And thus, sequencing is of these is known as whole-exome sequencing. The whole-exome sequencing allows identifying the variations in the protein-coding sites of any gene compared to sequencing a few genes together. The whole-exome sequencing is preferred widely due to its property to identify a mutation in a single exon. Identifying mutation in at the original site makes whole-exome sequencing an efficient method and enable to identify possible disease-causing mutation.
The advancement in the field of genomics has led to a significant reduction in the time and cost of genome sequencing. The related cost of sequencing with different sequencing techniques and strategies are of interest as they influence the scope and scale of the genomic research studies. Thus, it makes whole-exome sequencing much-preferred method than whole-genome sequencing.
The advantages of exome sequencing have resulted in the reduction of time and cost to a great extent. Approximately 2% of the genome is sequenced by the WES method; however, it generally sequences the exon at a deeper level it sequence to 100X. The technique enables sequencing through a process where the DNA and RNA are hybridized with the protein-coding site and is isolated from the non-coding site. Also, the data required for 100X sequencing is approximately 5- 6GB, whereas, in genome sequencing, it is nearly 90GB. Thus, these factors offer lower data storage, faster, cheaper, and more accessible data analysis. Therefore, owing to the above-mentioned factors, it is estimated that the market for whole-exome sequencing is likely to grow significantly during the forecast period.
Product & Services -Based Insights
In terms of product & services, the global whole exome sequencing market is segmented into system, kits and services. In 2018, the kits segment held largest share of the market. Also, the same segment is estimated to register the highest CAGR during the forecast period.
Global Whole Exome Sequencing Market, by Product & Services – 2018 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Technology-Based Insights
Based on technology, the global whole exome sequencing market is segmented into sequencing by synthesis, ion semiconductor sequencing and other technologies. The sequencing by synthesis segment held the largest market share in 2018 and the same segment is estimated to grow at the fastest rate during the forecast period.
Application-Based Insights
In terms of application, the global whole exome sequencing market is segmented into diagnostic, drug discovery and development, personalized medicine and others. In 2018, the diagnostics segment held largest share of the market. However, the drug discovery and developments segment is expected to register the highest CAGR during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Whole Exome Sequencing Market: Strategic Insights
Market Size Value in US$ 755.68 Million in 2018 Market Size Value by US$ 3,812.0 Million by 2027 Growth rate CAGR of 19.8% from 2019-2027 Forecast Period 2019-2027 Base Year 2019
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Whole Exome Sequencing Market: Strategic Insights
| Market Size Value in | US$ 755.68 Million in 2018 |
| Market Size Value by | US$ 3,812.0 Million by 2027 |
| Growth rate | CAGR of 19.8% from 2019-2027 |
| Forecast Period | 2019-2027 |
| Base Year | 2019 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The global whole exome sequencing market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.
Global Whole Exome Sequencing Market – by Product & Services
- Systems
- Kits
- Services
- Sequencing Services
- Data Analysis (Bioinformatics)
- Other Services
Global Whole Exome Sequencing Market – by Technology
- Sequencing By Synthesis
- Ion Semiconductor Sequencing
- Other Technologies
Global Whole Exome Sequencing Market – by Application
- Diagnostics
- Cancer Diagnostics
- Monogenic (Mendelian) Disorders Diagnostics
- Monogenic Types of Diabetes Diagnostics
- HIV Diagnostics
- Other Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Others
Global Whole Exome Sequencing Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South America and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Centogene AG
- F. Hoffmann-La Roche AG
- Psomagen, Inc. (previuosly Macrogen Corp.)
- Pacific Biosciences of California, Inc.
- Brooks Automation, Inc. (GENEWIZ, Inc.)
- Bio-Rad Laboratories, Inc.
- Eurofins Scientific
- Stratos Genomics
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Products & Service ; Technology ; Applications and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Whole Exome Sequencing Market – By Product & Service
1.3.2 Global Whole Exome Sequencing Market – By Technology
1.3.3 Global Whole Exome Sequencing Market – By Application
1.3.4 Global Whole Exome Sequencing Market – By Geography
2. Global Whole Exome Sequencing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Whole Exome Sequencing– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East and Africa – PEST Analysis
4.2.5 South and Central America – PEST Analysis
4.3 Expert Opinions
5. Global Whole Exome Sequencing Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Reduction in Time and Cost for Sequencing
5.1.2 Rising Need of Molecular Diagnosis
5.1.3 Increasing Application in Drug Discovery
5.2 Key Market Restraints
5.2.1 Ethical, Social and Legal Concerns For Whole Exome Sequencing
5.2.2 Dearth of Highly Skilled Professionals
5.3 Key Market Opportunity
5.3.1 Development of Personalized Medicine
5.4 Future Trend
5.4.1 Diagnosing and Treating Cancer Using Whole Exome Sequencing
5.5 Impact Analysis of Drivers and Restraints
6. Whole Exome Sequencing Market – Global Analysis
6.1 Global Whole Exome Sequencing Market Revenue Forecasts And Analysis
6.2 Global Whole Exome Sequencing Market, By Geography - Forecasts And Analysis
6.3 Performance Of Key Players
6.4 Positioning Of Key Players
7. Whole Exome Sequencing Market Analysis And Forecasts To 2027 – Product & Services
7.1 Overview
7.2 Global Whole Exome Sequencing Market Share by Product 2018 & 2027 (%)
7.3 Systems Market
7.3.1 Overview
7.3.2 Systems Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Kits Market
7.4.1 Overview
7.4.2 Kits Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Services Market
7.5.1 Overview
7.5.2 Services Market Revenue and Forecast to 2027 (US$ Mn)
7.5.3 Sequencing Services Market
7.5.3.1 Overview
7.5.3.2 Sequencing Services Market Revenue and Forecast to 2027 (US$ Mn)
7.5.4 Data Analysis (Bioinformatics) Services Market
7.5.4.1 Overview
7.5.4.2 Data Analysis (Bioinformatics) Services Market Revenue and Forecast to 2027 (US$ Mn)
7.5.5 Others Services Market
7.5.5.1 Overview
7.5.5.2 Others Services Market Revenue and Forecast to 2027 (US$ Mn)
8. Global Whole Exome Sequencing Market Analysis to 2027 - Technology
8.1 Overview
8.2 Global Whole Exome Sequencing Market Share by Technology 2018 & 2027 (%)
8.3 Sequencing by Synthesis
8.3.1 Overview
8.3.2 Sequencing by Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Ion Semiconductor Sequencing
8.4.1 Overview
8.4.2 Ion Semiconductor Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Other Technologies
8.5.1 Overview
8.5.2 Other Technologies Market Revenue and Forecasts to 2027 (US$ Mn)
9. Whole Exome Sequencing Market Analysis And Forecasts To 2027 – Application
9.1 Overview
9.2 Global Whole Exome Sequencing Market Share by Application 2018 & 2027 (%)
9.3 Diagnostics
9.3.1 Overview
9.3.2 Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.3 Cancer Diagnostics
9.3.3.1 Overview
9.3.3.2 Cancer Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.4 Monogenic (Mendelian) Disorders Diagnostics
9.3.4.1 Overview
9.3.4.2 Monogenic (Mendelian) Disorders Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.5 Monogenic Types of Diabetes Diagnostics
9.3.5.1 Overview
9.3.5.2 Monogenic Types of Diabetes Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.6 HIV Diagnostics
9.3.6.1 Overview
9.3.6.2 HIV Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7 Others Diagnostics
9.3.7.1 Overview
9.3.7.2 Others Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Drug Discovery & Development
9.4.1 Overview
9.4.2 Drug Discovery & Development Market Revenue and Forecast To 2027 (US$ Mn)
9.5 Personalized Medicine
9.5.1 Overview
9.5.2 Personalized Medicine Market Revenue and Forecasts To 2027 (US$ Mn)
9.6 Other Application
9.6.1 Overview
9.6.2 Other Application Market Revenue and Forecasts To 2027 (US$ Mn)
10. Whole Exome Sequencing Market Revenue And Forecasts To 2027 – Regional Analysis
10.1 North America Whole Sequencing Market
10.1.1 Overview
10.1.2 North America Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.3 North America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.1.3.1 North America Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.1.4 North America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.1.5 North America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.1.5.1 North America Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.1.6 North America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Country (%)
10.1.7 US Whole Exome Sequencing Market
10.1.7.1 US Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.2 US Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.1.7.2.1 US Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.1.7.3 US Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.1.7.4 US Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.1.7.4.1 US Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.1.8 Canada Whole Exome Sequencing Market
10.1.8.1 Canada Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.2 Canada Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.1.8.2.1 Canada Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.1.8.3 Canada Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.1.8.4 Canada Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.1.8.4.1 Canada Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.1.9 Mexico Whole Exome Sequencing Market
10.1.9.1 Mexico Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9.2 Mexico Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.1.9.2.1 Mexico Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.1.9.3 Mexico Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.1.9.4 Mexico Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.1.9.4.1 Mexico Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2 Europe Whole Exome Sequencing Market
10.2.1 Overview
10.2.2 Europe Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.3 Europe Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.2.3.1 Europe Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.4 Europe Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.2.5 Europe Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.2.5.1 Europe Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.6 Europe Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Country (%)
10.2.7 UK Whole Exome Sequencing Market
10.2.7.1 UK Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.7.2 UK Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.2.7.2.1 UK Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.7.3 UK Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.2.7.4 UK Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.2.7.4.1 UK Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.8 Germany Whole Exome Sequencing Market
10.2.8.1 Germany Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.8.2 Germany Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.2.8.2.1 Germany Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.8.3 Germany Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.2.8.4 Germany Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.2.8.4.1 Germany Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.9 France Whole Exome Sequencing Market
10.2.9.1 France Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.9.2 France Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.2.9.2.1 France Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.9.3 France Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.2.9.4 France Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.2.9.4.1 France Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.10 Spain Whole Exome Sequencing Market
10.2.10.1Spain Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.10.2Spain Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.2.10.2.1 Spain Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.10.3Spain Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.2.10.4Spain Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.2.10.4.1 Spain Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.11 Italy Whole Exome Sequencing Market
10.2.11.1Italy Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.11.2Italy Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.2.11.2.1.. Italy Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.2.11.3Italy Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.2.11.4Italy Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.2.11.4.1. Italy Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3 Asia Pacific Whole Exome Sequencing Market
10.3.1 Overview
10.3.2 Asia Pacific Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.3 Asia Pacific Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.3.3.1 Asia Pacific Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.4 Asia Pacific Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.3.5 Asia Pacific Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.3.5.1 Asia Pacific Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.6 Asia Pacific Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Country (%)
10.3.7 China Whole Exome Sequencing Market
10.3.7.1 China Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.7.2 China Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.3.7.2.1 China Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.7.3 China Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.3.7.4 China Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.3.7.4.1 China Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.8 Japan Whole Exome Sequencing Market
10.3.8.1 Japan Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.8.2 Japan Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.3.8.2.1 Japan Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.8.3 Japan Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.3.8.4 Japan Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.3.8.4.1 Japan Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.9 India Whole Exome Sequencing Market
10.3.9.1 India Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.9.2 India Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.3.9.2.1 India Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.9.3 India Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.3.9.4 India Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.3.9.4.1 India Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.10 Australia Whole Exome Sequencing Market
10.3.10.1Australia Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.10.2Australia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.3.10.2.1 Australia Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.10.3Australia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.3.10.4Australia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.3.10.4.1Australia Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.11 South Korea Whole Exome Sequencing Market
10.3.11.1South Korea Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.11.2South Korea Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.3.11.2.1South Korea Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.3.11.3South Korea Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.3.11.4South Korea Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.3.11.4.1South Korea Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.4 Middle East & Africa Whole Exome Sequencing Market
10.4.1 Overview
10.4.2 Middle East & Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.3 Middle East & Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.4.3.1 Middle East & Africa Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.4.4 Middle East & Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.4.5 Middle East & Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.4.5.1 Middle East & Africa Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.4.6 Middle East & Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Country (%)
10.4.7 UAE Whole Exome Sequencing Market
10.4.7.1 UAE Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.7.2 UAE Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.4.7.2.1 UAE Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.4.7.3 UAE Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.4.7.4 UAE Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.4.7.4.1 UAE Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.4.8 Saudi Arabia Whole Exome Sequencing Market
10.4.8.1 Saudi Arabia Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.8.2 Saudi Arabia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.4.8.2.1 Saudi Arabia Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.4.8.3 Saudi Arabia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.4.8.4 Saudi Arabia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.4.8.4.1 Saudi Arabia Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.4.9 South Africa Whole Exome Sequencing Market
10.4.9.1 South Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.9.2 South Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.4.9.2.1 South Africa Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.4.9.3 South Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.4.9.4 South Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.4.9.4.1 South Africa Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.5 South and Central America Whole Exome Sequencing Market
10.5.1 Overview
10.5.2 South and Central America Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.3 South and Central America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.5.3.1 South and Central America Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.5.4 South and Central America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.5.5 South and Central America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.5.5.1 South and Central America Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.5.6 South and Central America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Country (%)
10.5.7 Brazil Whole Exome Sequencing Market
10.5.7.1 Brazil Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.7.2 Brazil Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.5.7.2.1 Brazil Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.5.7.3 Brazil Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.5.7.4 Brazil Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.5.7.4.1 Brazil Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.5.8 Argentina Whole Exome Sequencing Market
10.5.8.1 Argentina Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.8.2 Argentina Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
10.5.8.2.1 Argentina Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
10.5.8.3 Argentina Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
10.5.8.4 Argentina Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10.5.8.4.1 Argentina Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
11. Whole Exome Sequencing Market –Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Whole Exome Sequencing Market, 2016-2019
11.3 Organic Developments
11.3.1 Overview
11.3.2 Organic Growth Strategies in the Whole Exome Sequencing Market, 2016-2019
11.4 Inorganic Developments
11.4.1 Overview
11.4.2 Inorganic Growth Strategies in the Whole Exome Sequencing Market, 2016-2019
12. Whole Exome Sequencing Market–Key Company Profiles
12.1 Stratos Genomics
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Bio-Rad Laboratories, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Eurofins Scientific
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Product Portfolio
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 F. Hoffmann-La Roche Ltd.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Pacific Bioscience of California, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 GENEWIZ
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Psomagen, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Thermo Fisher Scientific, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Illumina, Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Centogene
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product Portfolio
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Whole Exome Sequencing Market Revenue and Forecasts To 2027, By Product & Service (US$ Mn)
Table 2. North America Service Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 3. North America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 4. North America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 5. North America Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 6. US Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
Table 7. US Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 8. US Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 9. US Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 10. US Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 11. Canada Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
Table 12. Canada Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 13. Canada Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 14. Canada Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 15. Canada Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 16. Mexico Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
Table 17. Mexico Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 18. Mexico Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 19. Mexico Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 20. Mexico Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 21. Europe Whole Exome Sequencing Market Revenue and Forecasts To 2027, By Product & Service (US$ Mn)
Table 22. Europe Service Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 23. Europe Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 24. Europe Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 25. Europe Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 26. UK Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
Table 27. UK Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 28. UK Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 29. UK Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 30. UK Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 31. Germany Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
Table 32. Germany Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 33. Germany Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 34. Germany Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 35. Germany Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 36. France Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
Table 37. France Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 38. France Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 39. France Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 40. France Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 41. Spain Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
Table 42. Spain Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 43. Spain Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 44. Spain Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 45. Spain Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 46. Italy Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
Table 47. Italy Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 48. Italy Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 49. Italy Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 50. Italy Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 51. Asia Pacific Whole Exome Sequencing Market Revenue and Forecasts To 2027, By Product & Service (US$ Mn)
Table 52. Asia Pacific Service Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 53. Asia Pacific Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 54. Asia Pacific Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 55. Asia Pacific Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 56. China Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
Table 57. China Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 58. China Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 59. China Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 60. China Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 61. Japan Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
Table 62. Japan Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 63. Japan Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 64. Japan Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 65. Japan Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 66. India Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
Table 67. India Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 68. India Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 69. India Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 70. India Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 71. Australia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
Table 72. Australia Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 73. Australia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 74. Australia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 75. Australia Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 76. South Korea Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
Table 77. South Korea Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 78. South Korea Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 79. South Korea Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 80. South Korea Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 81. Middle East & Africa Whole Exome Sequencing Market Revenue and Forecasts To 2027, By Product & Service (US$ Mn)
Table 82. Middle East & Africa Service Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 83. Middle East & Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 84. Middle East & Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 85. Middle East & Africa Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 86. UAE Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
Table 87. UAE Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 88. UAE Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 89. UAE Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 90. UAE Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 91. Saudi Arabia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
Table 92. Saudi Arabia Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 93. Saudi Arabia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 94. Saudi Arabia Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 95. Saudi Arabia Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 96. South Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
Table 97. South Africa Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 98. South Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 99. South Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 100. South Africa Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 101. South and Central America Whole Exome Sequencing Market Revenue and Forecasts To 2027, By Product & Service (US$ Mn)
Table 102. South and Central America Service Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 103. South and Central America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 104. South and Central America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 105. South and Central America Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 106. Brazil Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
Table 107. Brazil Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 108. Brazil Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 109. Brazil Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 110. Brazil Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 111. Argentina Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Product & Service (US$ Mn)
Table 112. Argentina Service Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 113. Argentina Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
Table 114. Argentina Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Application (US$ Mn)
Table 115. Argentina Diagnostics Market Revenue and Forecasts to 2027, By Type (US$ Mn)
Table 116. Recent Organic Growth Strategies in the Whole Exome Sequencing Market
Table 117. Recent Inorganic Growth Strategies in the Whole Exome Sequencing Market
Table 118. Glossary of Terms, Whole Exome Sequencing Market
LIST OF FIGURES
Figure 1. Whole Exome Sequencing Market Segmentation
Figure 2. Whole Exome Sequencing Segmentation, By Region
Figure 3. Global Whole Exome Sequencing Market Overview
Figure 4. Systems Segment Held Largest Share Of The Product & Services Segment In Whole Exome Sequencing Market
Figure 5. Asia Pacific Region Is Expected To Show Remarkable Growth During The Forecast Period
Figure 6. Global Whole Exome Sequencing Market, By Geography (US$ Mn)
Figure 7. Global Whole Exome Sequencing Market- Leading Country Markets (US$ Mn)
Figure 8. Global Whole Exome Sequencing Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America PEST Analysis
Figure 14. Whole Exome Sequencing Market Impact Analysis of Drivers and Restraint
Figure 15. Global Whole Exome Sequencing Market – Revenue Forecasts And Analysis – 2018- 2027
Figure 16. Global Whole Exome Sequencing Market – By Geography Forecasts And Analysis – 2018- 2027
Figure 17. Market Positioning Of Key Player In Global Whole Exome Sequencing Market
Figure 18. Global Whole Exome Sequencing Market Share by Product 2018 & 2027 (%)
Figure 19. Systems Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Kits Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Services Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Sequencing Services Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Data Analysis (Bioinformatics) Services Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Others Services Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Global Whole Exome Sequencing Market Breakdown by Technology, 2018 & 2027 (%)
Figure 26. Sequencing by Synthesis Research Market Revenue And Forecasts to 2027 (US$ Mn)
Figure 27. Ion Semiconductor Sequencing Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 28. Other Technologies Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 29. Global Whole Exome Sequencing Market Share by Application 2018 & 2027 (%)
Figure 30. Diagnostics Market Revenue And Forecasts to 2027 (US$ Mn)
Figure 31. Cancer Diagnostics Market Revenue And Forecasts to 2027 (US$ Mn)
Figure 32. Monogenic (Mendelian) Disorders Diagnostics Market Revenue And Forecasts to 2027 (US$ Mn)
Figure 33. Monogenic Types of Diabetes Diagnostics Market Revenue And Forecasts to 2027 (US$ Mn)
Figure 34. HIV Diagnostics Market Revenue And Forecasts to 2027 (US$ Mn)
Figure 35. Others Diagnostics Market Revenue And Forecasts to 2027 (US$ Mn)
Figure 36. Drug Discovery & Development Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 37. Personalized Medicine Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 38. Other Application Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 39. North America Whole Exome Sequencing Market Revenue Overview, By Country (2018) (US$ Mn)
Figure 40. North America Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 41. North America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Country (%)
Figure 42. US Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 43. Canada Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 44. Mexico Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 45. Europe Whole Exome Sequencing Market Revenue Overview, By Country (2018) (US$ Mn)
Figure 46. Europe Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 47. Europe Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Country (%)
Figure 48. UK Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 49. Germany Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 50. France Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 51. Spain Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 52. Italy Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 53. Asia Pacific Whole Exome Sequencing Market Revenue Overview, By Country (2018) (US$ Mn)
Figure 54. Asia Pacific Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 55. Asia Pacific Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Country (%)
Figure 56. China Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 57. Japan Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 58. India Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 59. Australia Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 60. South Korea Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 61. Middle East & Africa Whole Exome Sequencing Market Revenue Overview, By Country (2018) (US$ Mn)
Figure 62. Middle East & Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 63. Middle East & Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Country (%)
Figure 64. UAE Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 65. Saudi Arabia Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 66. South Africa Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 67. South and Central America Whole Exome Sequencing Market Revenue Overview, By Country (2018) (US$ Mn)
Figure 68. South and Central America Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 69. South and Central America Whole Exome Sequencing Market Revenue and Forecasts to 2027, By Country (%)
Figure 70. Brazil Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 71. Argentina Whole Exome Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 72. Growth Strategies in the Whole Exome Sequencing Market, 2016-2019
The List of Companies
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Centogene AG
- F. Hoffmann-La Roche AG
- Psomagen, Inc. (previuosly Macrogen Corp.)
- Pacific Biosciences of California, Inc.
- Brooks Automation, Inc. (GENEWIZ, Inc.)
- Bio-Rad Laboratories, Inc.
- Eurofins Scientific
- Stratos Genomics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Whole Exome Sequencing Market
Aug 2019
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Aug 2019
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2019
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Aug 2019
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Aug 2019
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Aug 2019
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Aug 2019
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Aug 2019